NA
HCAT icon

Neuburgh Advisers’s Health Catalyst HCAT Stock Holding History

Neuburgh Advisers’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$593K Buy
+18,736
New +$737K 0.02% 421

Other funds holding HCAT

SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Neuburgh Advisers's HCAT Position: Q3 2019 in Review

Neuburgh Advisers opened a new position in Health Catalyst (HCAT) in Q3 2019: 18,736 shares worth $593K. The stake represents 0.02% of the portfolio and ranks #421 among its holdings.

86 funds tracked by Wall St. Rank hold HCAT as of Q3 2019.

  • Neuburgh Advisers held 18,736 shares of Health Catalyst worth $593K as of Q3 2019.
  • Health Catalyst was a new Neuburgh Advisers position in Q3 2019.
  • Health Catalyst made up 0.02% of Neuburgh Advisers's portfolio in Q3 2019, its #421 holding.
  • 86 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.